1 | almost | 6,065 |
2 | nearly | 3,629 |
3 | virtually | 850 |
4 | hualien | 12 |
5 | 'almost | 8 |
6 | sikang | 5 |
7 | jinyou | 4 |
8 | aquasonic® | 3 |
9 | bax/nt-3 | 3 |
10 | combusting | 3 |
11 | optical-optical | 3 |
12 | thrombotically | 3 |
13 | xunxi | 3 |
14 | 4/4029 | 2 |
15 | ann1/ann2 | 2 |
16 | coughstim | 2 |
17 | dchip | 2 |
18 | less-than | 2 |
19 | m08 | 2 |
20 | recertified | 2 |
21 | thefirst | 2 |
22 | triptoreline | 2 |
23 | two-to | 2 |
24 | 'org | 1 |
25 | -6759+13 | 1 |
26 | //clinicaltrials.gov/show/nct00773071 | 1 |
27 | 01/2006-09/2008 | 1 |
28 | 11.2-not | 1 |
29 | 11·5-not | 1 |
30 | 13-day-old | 1 |
31 | 19-to-34-year-olds | 1 |
32 | 1=definitely | 1 |
33 | 2-s. | 1 |
34 | 2.in | 1 |
35 | 24.3-not | 1 |
36 | 26·87-not | 1 |
37 | 26℃ | 1 |
38 | 27·0-not | 1 |
39 | 3-chlorophenol | 1 |
40 | :trpv3 | 1 |
41 | adh1/4 | 1 |
42 | adhseap | 1 |
43 | anti-m1 | 1 |
44 | antidepressants.for | 1 |
45 | approximately++ | 1 |
46 | arthotomy | 1 |
47 | astrocytes-tnf-α | 1 |
48 | at-l23 | 1 |
49 | atbrn2-3 | 1 |
50 | atomoxetine-and | 1 |
51 | baby.â | 1 |
52 | bci-performance | 1 |
53 | bcr-abl1-positive | 1 |
54 | bt-crops | 1 |
55 | c3/c3a | 1 |
56 | c8-c9 | 1 |
57 | cd3cd4 | 1 |
58 | cestrumines | 1 |
59 | co-sponsorship | 1 |
60 | conception.for | 1 |
61 | contacted.. | 1 |
62 | crp/tnf-alpha | 1 |
63 | cxl017-induced | 1 |
64 | cynopterus | 1 |
65 | d6-7 | 1 |
66 | delivery-almost | 1 |
67 | displayed—one | 1 |
68 | dtt-sensitive | 1 |
69 | eight-term | 1 |
70 | elemenone | 1 |
71 | enclosed-space | 1 |
72 | endothelin- | 1 |
73 | entice | 1 |
74 | fat1/fat2 | 1 |
75 | fenoximone | 1 |
76 | filifactor | 1 |
77 | fluorines | 1 |
78 | fully-matured | 1 |
79 | genetically-different | 1 |
80 | gimmicky | 1 |
81 | hbm.nearly | 1 |
82 | headwind | 1 |
83 | hyperinflation.in | 1 |
84 | iheyensis | 1 |
85 | il-1ri-/- | 1 |
86 | incepts | 1 |
87 | infrared-infrared | 1 |
88 | inquisitors | 1 |
89 | itpp-sp | 1 |
90 | jujunum | 1 |
91 | lymphoblastogenesis | 1 |
92 | magnamosis | 1 |
93 | mir-449 | 1 |
94 | mll-germline | 1 |
95 | naproxen-but | 1 |
96 | nced9-1 | 1 |
97 | ndm+/chd-was | 1 |
98 | ninety-six-well | 1 |
99 | outshining | 1 |
100 | p-interactions | 1 |
101 | p36lh48 | 1 |
102 | patients-33 | 1 |
103 | performedin | 1 |
104 | puncturefor | 1 |
105 | rap2.3-1 | 1 |
106 | recomendedfor | 1 |
107 | release-time | 1 |
108 | rr-ms. | 1 |
109 | semiselective | 1 |
110 | si-cellulose | 1 |
111 | similar-and | 1 |
112 | state-averaged | 1 |
113 | submits | 1 |
114 | t-phenotype | 1 |
115 | tam-cre/ifat1 | 1 |
116 | transilluminators | 1 |
117 | ufi-gel | 1 |
118 | variable.in | 1 |
119 | y422d | 1 |
1 | 'almost | 8 |
2 | 'org | 1 |
3 | -6759+13 | 1 |
4 | //clinicaltrials.gov/show/nct00773071 | 1 |
5 | 01/2006-09/2008 | 1 |
6 | 11.2-not | 1 |
7 | 11·5-not | 1 |
8 | 13-day-old | 1 |
9 | 19-to-34-year-olds | 1 |
10 | 1=definitely | 1 |
11 | 2-s. | 1 |
12 | 2.in | 1 |
13 | 24.3-not | 1 |
14 | 26·87-not | 1 |
15 | 26℃ | 1 |
16 | 27·0-not | 1 |
17 | 3-chlorophenol | 1 |
18 | 4/4029 | 2 |
19 | :trpv3 | 1 |
20 | adh1/4 | 1 |
21 | adhseap | 1 |
22 | almost | 6,065 |
23 | ann1/ann2 | 2 |
24 | anti-m1 | 1 |
25 | antidepressants.for | 1 |
26 | approximately++ | 1 |
27 | aquasonic® | 3 |
28 | arthotomy | 1 |
29 | astrocytes-tnf-α | 1 |
30 | at-l23 | 1 |
31 | atbrn2-3 | 1 |
32 | atomoxetine-and | 1 |
33 | baby.â | 1 |
34 | bax/nt-3 | 3 |
35 | bci-performance | 1 |
36 | bcr-abl1-positive | 1 |
37 | bt-crops | 1 |
38 | c3/c3a | 1 |
39 | c8-c9 | 1 |
40 | cd3cd4 | 1 |
41 | cestrumines | 1 |
42 | co-sponsorship | 1 |
43 | combusting | 3 |
44 | conception.for | 1 |
45 | contacted.. | 1 |
46 | coughstim | 2 |
47 | crp/tnf-alpha | 1 |
48 | cxl017-induced | 1 |
49 | cynopterus | 1 |
50 | d6-7 | 1 |
51 | dchip | 2 |
52 | delivery-almost | 1 |
53 | displayed—one | 1 |
54 | dtt-sensitive | 1 |
55 | eight-term | 1 |
56 | elemenone | 1 |
57 | enclosed-space | 1 |
58 | endothelin- | 1 |
59 | entice | 1 |
60 | fat1/fat2 | 1 |
61 | fenoximone | 1 |
62 | filifactor | 1 |
63 | fluorines | 1 |
64 | fully-matured | 1 |
65 | genetically-different | 1 |
66 | gimmicky | 1 |
67 | hbm.nearly | 1 |
68 | headwind | 1 |
69 | hualien | 12 |
70 | hyperinflation.in | 1 |
71 | iheyensis | 1 |
72 | il-1ri-/- | 1 |
73 | incepts | 1 |
74 | infrared-infrared | 1 |
75 | inquisitors | 1 |
76 | itpp-sp | 1 |
77 | jinyou | 4 |
78 | jujunum | 1 |
79 | less-than | 2 |
80 | lymphoblastogenesis | 1 |
81 | m08 | 2 |
82 | magnamosis | 1 |
83 | mir-449 | 1 |
84 | mll-germline | 1 |
85 | naproxen-but | 1 |
86 | nced9-1 | 1 |
87 | ndm+/chd-was | 1 |
88 | nearly | 3,629 |
89 | ninety-six-well | 1 |
90 | optical-optical | 3 |
91 | outshining | 1 |
92 | p-interactions | 1 |
93 | p36lh48 | 1 |
94 | patients-33 | 1 |
95 | performedin | 1 |
96 | puncturefor | 1 |
97 | rap2.3-1 | 1 |
98 | recertified | 2 |
99 | recomendedfor | 1 |
100 | release-time | 1 |
101 | rr-ms. | 1 |
102 | semiselective | 1 |
103 | si-cellulose | 1 |
104 | sikang | 5 |
105 | similar-and | 1 |
106 | state-averaged | 1 |
107 | submits | 1 |
108 | t-phenotype | 1 |
109 | tam-cre/ifat1 | 1 |
110 | thefirst | 2 |
111 | thrombotically | 3 |
112 | transilluminators | 1 |
113 | triptoreline | 2 |
114 | two-to | 2 |
115 | ufi-gel | 1 |
116 | variable.in | 1 |
117 | virtually | 850 |
118 | xunxi | 3 |
119 | y422d | 1 |
1 | approximately++ | 1 |
2 | il-1ri-/- | 1 |
3 | endothelin- | 1 |
4 | contacted.. | 1 |
5 | 2-s. | 1 |
6 | rr-ms. | 1 |
7 | rap2.3-1 | 1 |
8 | nced9-1 | 1 |
9 | //clinicaltrials.gov/show/nct00773071 | 1 |
10 | anti-m1 | 1 |
11 | tam-cre/ifat1 | 1 |
12 | ann1/ann2 | 2 |
13 | fat1/fat2 | 1 |
14 | atbrn2-3 | 1 |
15 | bax/nt-3 | 3 |
16 | -6759+13 | 1 |
17 | at-l23 | 1 |
18 | patients-33 | 1 |
19 | :trpv3 | 1 |
20 | adh1/4 | 1 |
21 | cd3cd4 | 1 |
22 | d6-7 | 1 |
23 | 01/2006-09/2008 | 1 |
24 | m08 | 2 |
25 | p36lh48 | 1 |
26 | 4/4029 | 2 |
27 | mir-449 | 1 |
28 | c8-c9 | 1 |
29 | c3/c3a | 1 |
30 | crp/tnf-alpha | 1 |
31 | y422d | 1 |
32 | cxl017-induced | 1 |
33 | state-averaged | 1 |
34 | recertified | 2 |
35 | infrared-infrared | 1 |
36 | fully-matured | 1 |
37 | 13-day-old | 1 |
38 | atomoxetine-and | 1 |
39 | similar-and | 1 |
40 | headwind | 1 |
41 | enclosed-space | 1 |
42 | entice | 1 |
43 | bci-performance | 1 |
44 | release-time | 1 |
45 | triptoreline | 2 |
46 | mll-germline | 1 |
47 | fenoximone | 1 |
48 | elemenone | 1 |
49 | displayed—one | 1 |
50 | t-phenotype | 1 |
51 | si-cellulose | 1 |
52 | semiselective | 1 |
53 | dtt-sensitive | 1 |
54 | bcr-abl1-positive | 1 |
55 | sikang | 5 |
56 | outshining | 1 |
57 | combusting | 3 |
58 | 'org | 1 |
59 | xunxi | 3 |
60 | optical-optical | 3 |
61 | ufi-gel | 1 |
62 | ninety-six-well | 1 |
63 | 3-chlorophenol | 1 |
64 | coughstim | 2 |
65 | eight-term | 1 |
66 | jujunum | 1 |
67 | less-than | 2 |
68 | hualien | 12 |
69 | 2.in | 1 |
70 | variable.in | 1 |
71 | hyperinflation.in | 1 |
72 | performedin | 1 |
73 | two-to | 2 |
74 | adhseap | 1 |
75 | dchip | 2 |
76 | co-sponsorship | 1 |
77 | itpp-sp | 1 |
78 | conception.for | 1 |
79 | antidepressants.for | 1 |
80 | recomendedfor | 1 |
81 | puncturefor | 1 |
82 | filifactor | 1 |
83 | ndm+/chd-was | 1 |
84 | 19-to-34-year-olds | 1 |
85 | cestrumines | 1 |
86 | fluorines | 1 |
87 | lymphoblastogenesis | 1 |
88 | iheyensis | 1 |
89 | magnamosis | 1 |
90 | p-interactions | 1 |
91 | bt-crops | 1 |
92 | transilluminators | 1 |
93 | inquisitors | 1 |
94 | submits | 1 |
95 | incepts | 1 |
96 | cynopterus | 1 |
97 | genetically-different | 1 |
98 | 27·0-not | 1 |
99 | 11.2-not | 1 |
100 | 24.3-not | 1 |
101 | 11·5-not | 1 |
102 | 26·87-not | 1 |
103 | almost | 6,065 |
104 | 'almost | 8 |
105 | delivery-almost | 1 |
106 | thefirst | 2 |
107 | naproxen-but | 1 |
108 | jinyou | 4 |
109 | gimmicky | 1 |
110 | 1=definitely | 1 |
111 | thrombotically | 3 |
112 | virtually | 850 |
113 | nearly | 3,629 |
114 | hbm.nearly | 1 |
115 | arthotomy | 1 |
116 | 26℃ | 1 |
117 | baby.â | 1 |
118 | aquasonic® | 3 |
119 | astrocytes-tnf-α | 1 |